Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder
Othmer, E.; Othmer, S.C.
Journal of Clinical Psychiatry 48(5): 201-203
1987
ISSN/ISBN: 0160-6689 PMID: 2883173 Document Number: 411
After 4 weeks' treatment with buspirone, sexual function was normalized in 8 of 10 patients with generalized anxiety disorder. Nine of the patients had reported decreased sexual function before treatment. Buspirone appears to offer a clinical advantage over existing anxiolytics, which are usually associated with impairment of sexual function.
Document emailed within 1 workday
Related Documents
Mossman, S.A.; Luft, M.J.; Schroeder, H.K.; Varney, S.T.; Fleck, D.E.; Barzman, D.H.; Gilman, R.; DelBello, M.P.; Strawn, J.R. 2017: The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 29(4): 227-234aBiebl, W.; Deisenhammer, E.A.; Lehofer, M.; Muigg, W.; Posch, C.; Zeilerbauer, J. 1993: Anxiety neurosis--avoidant behavior--depression. a comparison between panic disorder and generalized anxiety disorder Psychotherapie Psychosomatik Medizinische Psychologie 43(1): 10-14
Rzewuska, M.; Sobucka, K. 1993: Buspirone in the treatment of Generalized Anxiety Disorders Psychiatria Polska 27(5): 545-561
Hedges, D.W.; Reimherr, F.W.; Strong, R.E.; Halls, C.H.; Rust, C. 1996: An open trial of nefazodone in adult patients with generalized anxiety disorder Psychopharmacology Bulletin 32(4): 671-676
Ballenger, J.C.; Davidson, J.R.; Lecrubier, Y.; Nutt, D.J.; Borkovec, T.D.; Rickels, K.; Stein, D.J.; Wittchen, H.U. 2001: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety Journal of Clinical Psychiatry 62(Suppl): 53-58
Gasparini, M.; Dalla Pria, S.; D'Aietti, V. 1987: Generalized anxiety disorder in labor Minerva Ginecologica 39(3): 141-144
Schneider, L.S. 1996: Overview of generalized anxiety disorder in the elderly Journal of Clinical Psychiatry 57(Suppl 7): 34-45; Discussion: 52-54
Vanderlaan, J. 2008: Pregnancy and birth with generalized anxiety disorder Midwifery Today with International Midwife 88: 28-29; 67-68
Brawman-Mintzer, O.; Lydiard, R.B. 1997: Biological basis of generalized anxiety disorder Journal of Clinical Psychiatry 58(Suppl): 16-25
Berber, M.J. 2000: WATCHERS: recognizing generalized anxiety disorder Journal of Clinical Psychiatry 61(6): 447
Ninan, P.T. 2001: Generalized anxiety disorder: diagnosis, neurobiology, and treatment Psychopharmacology Bulletin 35(1): 65-76
Pollack, M.H. 2001: Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission Journal of Clinical Psychiatry 62(Suppl): 20-25
Kamrowska, A.; Gmitrowicz, A. 2016: Treatment of generalized anxiety disorder in terms of cognitive behavioral Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 40(236): 141-143
2012: Pharmacotherapy versus psychotherapy: treatment of generalized anxiety disorder MMW Fortschritte der Medizin 154(2): 78-79
Schweizer, E.; Rickels, K. 1996: The long-term management of generalized anxiety disorder: issues and dilemmas Journal of Clinical Psychiatry 57(Suppl): 9
Starcevic, V.; Fallon, S.; Uhlenhuth, E.H. 1994: The frequency and severity of generalized anxiety disorder symptoms. Toward a less cumbersome conceptualization Journal of Nervous and Mental Disease 182(2): 80-84
Allgulander, C.; Cloninger, C.R.; Przybeck, T.R.; Brandt, L. 1998: Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder Psychopharmacology Bulletin 34(2): 165-166
Bystritsky, A.; Kerwin, L.; Feusner, J.D.; Vapnik, T. 2008: A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder Psychopharmacology Bulletin 41(1): 46-51
Bereza, B.G.; Machado, Márcio.; Ravindran, A.V.; Einarson, T.R. 2012: Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 57(8): 470-478
Ballenger, J.C.; McDonald, S.; Noyes, R.; Rickels, K.; Sussman, N.; Woods, S.; Patin, J.; Singer, J. 1991: The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder Psychopharmacology Bulletin 27(2): 171-179